ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype (2017)
- Authors:
- Lucena-Araújo, Antonio Roberto
- Coelho-Silva, Juan L.
- Pereira-Martins, Diego A.
- Thomé, Carolina
- Scheucher, Priscila S.
- Lange, Ana P.
- Paiva, Helder H.
- Hemmelgarn, Benjamin T.
- Morais-Sobral, Mariana Carolina
- Azevedo, Elisa A.
- Franca-Neto, Pedro L.
- Franca, Rafael F.
- Silva, Cleide L.
- Krause, Alexandre
- Rego, Eduardo Magalhães
- USP affiliated authors: SCHEUCHER, PRISCILA SANTOS - FMRP ; REGO, EDUARDO MAGALHÃES - FMRP
- Unidade: FMRP
- DOI: 10.18632/oncotarget.14295
- Subjects: LEUCEMIA; APOPTOSE; TRANSPLANTE DE MEDULA ÓSSEA
- Keywords: Acute promyelocytic leukemia; ΔNp73; Apoptosis; Bone marrow transplantation; Lentiviral gene transfer
- Language: Inglês
- Imprenta:
- Source:
- Título: Oncotarget
- ISSN: 1949-2553
- Volume/Número/Paginação/Ano: v. 8, n. 5, p. 8475-8483, 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
LUCENA-ARAÚJO, Antonio Roberto et al. ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype. Oncotarget, v. 8, n. 5, p. 8475-8483, 2017Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.14295. Acesso em: 11 fev. 2026. -
APA
Lucena-Araújo, A. R., Coelho-Silva, J. L., Pereira-Martins, D. A., Thomé, C., Scheucher, P. S., Lange, A. P., et al. (2017). ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype. Oncotarget, 8( 5), 8475-8483. doi:10.18632/oncotarget.14295 -
NLM
Lucena-Araújo AR, Coelho-Silva JL, Pereira-Martins DA, Thomé C, Scheucher PS, Lange AP, Paiva HH, Hemmelgarn BT, Morais-Sobral MC, Azevedo EA, Franca-Neto PL, Franca RF, Silva CL, Krause A, Rego EM. ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype [Internet]. Oncotarget. 2017 ; 8( 5): 8475-8483.[citado 2026 fev. 11 ] Available from: https://doi.org/10.18632/oncotarget.14295 -
Vancouver
Lucena-Araújo AR, Coelho-Silva JL, Pereira-Martins DA, Thomé C, Scheucher PS, Lange AP, Paiva HH, Hemmelgarn BT, Morais-Sobral MC, Azevedo EA, Franca-Neto PL, Franca RF, Silva CL, Krause A, Rego EM. ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype [Internet]. Oncotarget. 2017 ; 8( 5): 8475-8483.[citado 2026 fev. 11 ] Available from: https://doi.org/10.18632/oncotarget.14295 - Overexpression of KMT2E is associated with lower ROS generation with arsenic trioxide treatment and higher granulocytic differentiation rate in response to atra-based treatment in acute promyelocytic leukemia cell lines
- Pharmacological IRS1/2 inhibition induces apoptosis in BCR-ABL1T315I mutant cells
- Reversine triggers mitotic catastrophe and apoptosis in BCR-ABL positive cells
- Proliferação e morte celular programada na gênese da leucemia promielocítica aguda no modelo transgênico hCG-PML-RAR'alfa'
- The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study
- Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia
- Metformin reduces tumor burden and splenomegaly in JAK2V617F murine models
- Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells
- Pharmacological IGF1R/IRS inhibitor, NT157, effectively induces apoptosis and CDKN1A expression in acute lymphoblastic leukemia cells
- The pharmacological IGF1R-IRS1/2 inhibitor NT157 presents multiple anti-neoplastic effects in myeloproliferative neoplasms
Informações sobre o DOI: 10.18632/oncotarget.14295 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
